These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25849660)

  • 1. Treat the brain and treat the periphery: toward a holistic approach to major depressive disorder.
    Zheng X; Zhang X; Wang G; Hao H
    Drug Discov Today; 2015 May; 20(5):562-8. PubMed ID: 25849660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel investigational drugs targeting IL-6 signaling for the treatment of depression.
    Fonseka TM; McIntyre RS; Soczynska JK; Kennedy SH
    Expert Opin Investig Drugs; 2015 Apr; 24(4):459-75. PubMed ID: 25585966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular network of neuronal autophagy in the pathophysiology and treatment of depression.
    Jia J; Le W
    Neurosci Bull; 2015 Aug; 31(4):427-34. PubMed ID: 26254058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of action of antidepressive drugs: new approaches].
    David DJ
    Encephale; 2012 Dec; 38 Suppl 2():S45-8. PubMed ID: 23279957
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.
    Stahl SM; Zhang L; Damatarca C; Grady M
    J Clin Psychiatry; 2003; 64 Suppl 14():6-17. PubMed ID: 14658930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal temporal difference reward-learning signals in major depression.
    Kumar P; Waiter G; Ahearn T; Milders M; Reid I; Steele JD
    Brain; 2008 Aug; 131(Pt 8):2084-93. PubMed ID: 18579575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New hypothesis and treatment targets of depression: an integrated view of key findings.
    Cai S; Huang S; Hao W
    Neurosci Bull; 2015 Feb; 31(1):61-74. PubMed ID: 25575479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of depression: an overview of the current science.
    Elder BL; Mosack V
    Issues Ment Health Nurs; 2011; 32(4):192-202. PubMed ID: 21355753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.
    Bellani M; Dusi N; Yeh PH; Soares JC; Brambilla P
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1544-52. PubMed ID: 21138750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.
    Correll GE; Futter GE
    Pain Med; 2006; 7(1):92-5. PubMed ID: 16533209
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory cytokines, growth factors, and depression.
    Lotrich F
    Curr Pharm Des; 2012; 18(36):5920-35. PubMed ID: 22681170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate hypothesis of depression and its consequences for antidepressant treatments.
    Musazzi L; Treccani G; Popoli M
    Expert Rev Neurother; 2012 Oct; 12(10):1169-72. PubMed ID: 23082730
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric major depressive disorder: neurobiology and implications for early intervention.
    Cullen K; Klimes-Dougan B; Kumra S; Schulz SC
    Early Interv Psychiatry; 2009 Aug; 3(3):178-88. PubMed ID: 22640381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular neurobiology of major depressive disorder.
    Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():275-6. PubMed ID: 26169576
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitric oxide: Antidepressant mechanisms and inflammation.
    Ghasemi M
    Adv Pharmacol; 2019; 86():121-152. PubMed ID: 31378250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Major depressive disorder: factors of risk, vulnerability and protection].
    Olié E; Courtet P
    Encephale; 2010 Dec; 36 Suppl 5():S117-22. PubMed ID: 21211630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.
    Trivedi MH; Lin EH; Katon WJ
    CNS Spectr; 2007 Aug; 12(8 Suppl 13):1-27. PubMed ID: 17986951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the role of glutamate in the pathophysiology of depression.
    Mitchell ND; Baker GB
    Acta Psychiatr Scand; 2010 Sep; 122(3):192-210. PubMed ID: 20105149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.